Company

Carbiotix is an award-winning biotechnology company pioneering microbiome healthcare through a range of cost-effective gut health testing services and a portfolio of microbiome modulators covering prebiotic ingredients, medical foods and therapeutics.

Read More »

Gut Health Testing

Gut health testing

Carbiotix low-cost gut health testing services are offered to consumers, companies and others as a means to cost effectively track gut health over time and overcome the natural variability associated with gut microbiome testing. The gut health tests serve as both discovery and diagnostic platform as well as assist with verifying and amplifying the efficacy of Carbiotix microbiome modulators.

View Services »

Microbiome Modulators

Microbiome Modulators

Carbiotix is developing and bringing to market a portfolio of microbiome modulators covering second generation prebiotic ingredients, medical foods and novel therapeutics. This portfolio will allow Carbiotix to leverage multiple delivery modes and industry partnerships, provide personalised microbiome modulators, and effectively address a list of leading chronic and metabolic diseases.

View Modulators »

Track your gut health

Services

OneGut
OneGut™

The most reliable and cost effective consumer gut health test on the market.

Read more »
LinkGut
LinkGut™

A white label service for those interested in offering their own gut health test.

Read more »
StudyGut
StudyGut™

A reliable and cost effective testing service for gut health related clinical studies.

Read more »
Available worldwide

Gut health starts with fiber

Modulators

It is the belief of Carbiotix that activity within the gut microbiome is more important than the presence of specific bacteria species. As such, the company is focused on engineering microbiome modulators to restore and optimize gut microbiome metabolic processes and thereby obtain a desired therapeutic effect through an improved metabolic profile.

Microbiome modulater graph

Unlocking the potential of fiber

Investors

Carbiotix is an award-winning public biotechnology company pioneering microbiome healthcare through a range of cost-effective gut health testing services and a portfolio of microbiome modulators covering prebiotic ingredients, medical foods and therapeutics.

Financial Calendar

Aug 11, 2020

Halvårsrapport


Nov 10, 2020

Delårsrapport 3


Feb 18, 2021

Bokslutskommuniké


Full financial calendar »

Stock

Latest price: 4.855 SEK
Updated at: Sep 23, 2020, 05:10